Fn14•Trail Effectively Inhibits Hepatocellular Carcinoma Growth

Open Access

Peer-reviewed

Research Article

Alexandra Aronin,

Affiliation Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
⨯
Shira Amsili,

Affiliation KAHR Medical LTD, Jerusalem, Israel
⨯
Tatyana B. Prigozhina,

Affiliation Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
⨯
Kobi Tzdaka,

Affiliation Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
⨯
Jacob Rachmilewitz,

Affiliation Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
⨯
Noam Shani,

Affiliation KAHR Medical LTD, Jerusalem, Israel
⨯
Mark L. Tykocinski,

Affiliation Office of the Dean, Jefferson Medical College, Philadelphia, Pennsylvania, United States of America
⨯
Michal Dranitzki Elhalel

* E-mail: michale@hadassah.org.il

Affiliation Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
⨯

Reader Comments (0)

Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Genetically modified animals
Is the Subject Area "Genetically modified animals" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.
Hepatocytes
Is the Subject Area "Hepatocytes" applicable to this article?

Thanks for your feedback.
Cell fusion
Is the Subject Area "Cell fusion" applicable to this article?

Thanks for your feedback.